[go: up one dir, main page]

CL2008001795A1 - USE OF AN ANTAGONIST PAR1 IN THE TREATMENT OF ATRIAL FIBRILATION. - Google Patents

USE OF AN ANTAGONIST PAR1 IN THE TREATMENT OF ATRIAL FIBRILATION.

Info

Publication number
CL2008001795A1
CL2008001795A1 CL200801795A CL2008001795A CL2008001795A1 CL 2008001795 A1 CL2008001795 A1 CL 2008001795A1 CL 200801795 A CL200801795 A CL 200801795A CL 2008001795 A CL2008001795 A CL 2008001795A CL 2008001795 A1 CL2008001795 A1 CL 2008001795A1
Authority
CL
Chile
Prior art keywords
par1
antagonist
treatment
atrial fibrilation
fibrilation
Prior art date
Application number
CL200801795A
Other languages
Spanish (es)
Inventor
Michel Le Grand Bruno Le Perez
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of CL2008001795A1 publication Critical patent/CL2008001795A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CL200801795A 2007-06-19 2008-06-17 USE OF AN ANTAGONIST PAR1 IN THE TREATMENT OF ATRIAL FIBRILATION. CL2008001795A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0755848A FR2917622B1 (en) 2007-06-19 2007-06-19 USE OF A PAR1 ANTAGONIST IN THE TREATMENT OF ATRIAL FIBRILLATION.

Publications (1)

Publication Number Publication Date
CL2008001795A1 true CL2008001795A1 (en) 2008-10-10

Family

ID=38973629

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200801795A CL2008001795A1 (en) 2007-06-19 2008-06-17 USE OF AN ANTAGONIST PAR1 IN THE TREATMENT OF ATRIAL FIBRILATION.

Country Status (6)

Country Link
AR (1) AR067061A1 (en)
CL (1) CL2008001795A1 (en)
FR (1) FR2917622B1 (en)
PA (1) PA8784901A1 (en)
TW (1) TW200908977A (en)
WO (1) WO2008155335A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902427B1 (en) * 2006-06-19 2008-08-22 Pierre Fabre Medicament Sa PHENYLPENTADIENOYLE DERIVATIVES
FR2902426B1 (en) 2006-06-19 2008-09-05 Pierre Fabre Medicament Sa CINNAMOYL-PIPERAZINE DERIVATIVES
CN104447485A (en) * 2015-01-13 2015-03-25 佛山市赛维斯医药科技有限公司 Chemical compound of structure containing nitrile benzene and diene adamantine and preparation method and application thereof
CN104478781A (en) * 2015-01-13 2015-04-01 佛山市赛维斯医药科技有限公司 Diene adamantane compound and preparation method and usage thereof
CN104478782B (en) * 2015-01-13 2016-03-16 佛山市赛维斯医药科技有限公司 One class contains compound and the purposes of alkoxyphenyl radical and diene fluoroadamantane structure
CN104496879A (en) * 2015-01-13 2015-04-08 佛山市赛维斯医药科技有限公司 Nitrile-based benzene and diene fluoro-adamantane contained structure compound and application
TR201601548A2 (en) * 2016-02-05 2018-03-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A PHARMACEUTICAL COMPOSITION OF VORAPAKSAR AND METOPROLOL
WO2017134200A1 (en) * 2016-02-05 2017-08-10 Sanovel Ilac Sanayi Ve Ticaret A.S. A novel pharmaceutical composition of vorapaxar and metoprolol
KR102268589B1 (en) * 2019-04-29 2021-06-24 사회복지법인 삼성생명공익재단 Method for selecting stem cells with high efficiency productivity of extracellular vesicles using the activity of protease-activated receptor-mediated signaling pathways

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61106564A (en) * 1984-10-30 1986-05-24 Terumo Corp Unsaturated fatty acid amide derivative and inhibitor of blood platelet aggregation containing same
JPS61137866A (en) * 1984-12-07 1986-06-25 Terumo Corp Imidazole derivative, and platelet coagulation suppressing agent contanining same

Also Published As

Publication number Publication date
FR2917622B1 (en) 2009-10-23
WO2008155335A1 (en) 2008-12-24
AR067061A1 (en) 2009-09-30
FR2917622A1 (en) 2008-12-26
TW200908977A (en) 2009-03-01
PA8784901A1 (en) 2009-01-23

Similar Documents

Publication Publication Date Title
LTC2340031I2 (en) GDF TRAPS FOR USE IN THE TREATMENT OF ANEMIA
SMT201500206B (en) Spiro-oxindolic compounds and their use as therapeutic agents
BRPI0920216A2 (en) multiple-dose intraoral dosage form and use thereof
BRPI0919438A2 (en) polyester blends and use of polyester blends
CL2008001795A1 (en) USE OF AN ANTAGONIST PAR1 IN THE TREATMENT OF ATRIAL FIBRILATION.
HRP20180718T1 (en) OLIGOPEPTID COMPOUNDS AND THEIR USE
BRPI0822104A2 (en) ANTIMICROBIAN COMPOSITIONS AND METHODS FOR THE USE OF THE SAME
BRPI0821668A2 (en) Use
SMT201500218B (en) Aryl-phenylsulfonamido-cycloalkyl compounds and their use
DK2300609T3 (en) Newly known flagellin-based immunoadjuvant compounds and their use
CL2008001076A1 (en) COMPOUNDS DERIVED FROM SULFONAMIDE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER.
BRPI0915299A2 (en) polyamide, composition comprising such polyamide and use thereof
BRPI0807908A2 (en) IMPROVEMENTS IN MEDICAL COMPOSITIONS.
BRPI0813955A2 (en) therapeutic compositions and their use
BRPI0907365A2 (en) Antimicrobial Composition and Use
BRPI0922233A2 (en) compounds, pharmaceutical compositions and methods for use in the treatment of metabolic syndromes.
BRPI0912292A2 (en) compositions and methods for the use of cells in the treatment of cardiac tissue.
BRPI0818766A2 (en) Substituted N-phenylpyrrolidinylmethylpyrrolidinamides and their therapeutic use
BRPI0919794A2 (en) device for intracorporeal use, and composed
BRPI0913175A2 (en) antiballistic article, and, use of it.
CL2008000110A1 (en) USE OF COMPOUNDS DERIVED FROM PIRANONA SUBSTITUTED FOR THE TREATMENT OF METABOLIC SYNDROME; AND COMPOUNDS DERIVED FROM PIRANONA SUBSTITUTED.
BRPI0911772A2 (en) compound, pharmaceutical composition, and use of the compound.
FR2930124B1 (en) DISABLED FURNITURE
SMT201600217B (en) FURANCARBOSSAMIDS SUBSTITUTED AND THEIR USE
EP2335010A4 (en) CYLINDER AND CYLINDER COMPRISING THE SAME